Complementary and Alternative Medicine for Anti Aging & Longevity Market (By Intervention : Traditional Alternative Medicine/Botanicals, Body Healing, Mind Healing, External Energy Healing, Sensory Healing; By Customer: High Net Worth (HNW) Individuals, Very High Net Worth (VHNW) Individuals, Ultra-high Net Worth (UHNW) Individuals) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20222030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Complementary and Alternative Medicine for Anti Aging & Longevity Market, By Intervention

7.1.  Complementary and Alternative Medicine for Anti Aging & Longevity Market, by Intervention, 2021-2030

7.1.1.    Traditional Alternative Medicine/Botanicals

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Body Healing

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Mind Healing

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    External Energy Healing

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Sensory Healing

7.1.5.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Complementary and Alternative Medicine for Anti Aging & Longevity Market, By Customer

8.1.  Complementary and Alternative Medicine for Anti Aging & Longevity Market, by Customer, 2021-2030

8.1.1.    High Net Worth (HNW) Individuals

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Very High Net Worth (VHNW) Individuals

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Ultra-high Net Worth (UHNW) Individuals

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Complementary and Alternative Medicine for Anti Aging & Longevity Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Intervention (2017-2030)

9.1.2.    Market Revenue and Forecast, by Customer (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Intervention (2017-2030)

9.2.2.    Market Revenue and Forecast, by Customer (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Intervention (2017-2030)

9.3.2.    Market Revenue and Forecast, by Customer (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Intervention (2017-2030)

9.4.2.    Market Revenue and Forecast, by Customer (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Intervention (2017-2030)

9.5.2.    Market Revenue and Forecast, by Customer (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by Customer (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Intervention (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by Customer (2017-2030)

Chapter 10.  Company Profiles

10.1.              Anadolu Medical Center

10.1.1.  Company Overview

10.1.2.  Intervention Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Sinomedica

10.2.1.  Company Overview

10.2.2.  Intervention Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Acupuncture Enfants

10.3.1.  Company Overview

10.3.2.  Intervention Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Ayurveda Kuwait

10.4.1.  Company Overview

10.4.2.  Intervention Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Maya Reiki School

10.5.1.  Company Overview

10.5.2.  Intervention Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Maylilacs

10.6.1.  Company Overview

10.6.2.  Intervention Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Al Zuhair Holistic Medicine Center

10.7.1.  Company Overview

10.7.2.  Intervention Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Ayurmana By Dharma Ayurveda

10.8.1.  Company Overview

10.8.2.  Intervention Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Trinicum

10.9.1.  Company Overview

10.9.2.  Intervention Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Miskawaan Health Group

10.10.1.               Company Overview

10.10.2.               Intervention Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms